Viewing Study NCT02151513


Ignite Creation Date: 2025-12-18 @ 9:46 AM
Ignite Modification Date: 2025-12-23 @ 9:48 PM
Study NCT ID: NCT02151513
Status: None
Last Update Posted: 2023-06-09 00:00:00
First Post: 2014-05-28 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
Sponsor: None
Organization:

Study Overview

Official Title: Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
Status: None
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Biomarkers of immune function will be measured before and after patients receive an intrathecal pain pump for management of cancer pain.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: